How Lion's Mane Stimulates Nerve Growth Factor — and Why That Matters

Educational content: This article summarizes peer-reviewed scientific research on Hericium erinaceus and Nerve Growth Factor. These statements have not been evaluated by the Food and Drug Administration. Lion's mane is a food — it is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Consult your physician regarding any neurological or health concerns.

Nerve Growth Factor (NGF) is a protein the brain requires to maintain and repair neurons throughout life. Its levels decline with age, and that decline is associated in research with Alzheimer's disease, Parkinson's disease, and age-related memory loss. Lion's mane is the only widely consumed food known to contain compounds that directly stimulate NGF synthesis inside the central nervous system. The mechanism has been characterized to the molecular level: two classes of terpenoids, hericenones and erinacines, cross the blood-brain barrier and induce NGF production in the cells that surround and support neurons.

On this page

• What Nerve Growth Factor does and why it declines

• How hericenones and erinacines were discovered

• The blood-brain barrier problem and how lion's mane addresses it

• What this mechanism means clinically

• What this means for your plate

What Nerve Growth Factor does and why its decline matters

NGF is a member of the neurotrophin family — proteins that regulate the growth, maintenance, and survival of specific neurons. In the peripheral nervous system, NGF is essential to sensory and sympathetic neurons. In the central nervous system, it is critical to the cholinergic neurons of the basal forebrain.

NGF does more than support cell survival. It regulates synaptic plasticity — the brain's capacity to strengthen or weaken connections between neurons in response to experience, which is the cellular basis of learning and memory. When NGF is adequate, neurons form connections, repair damage, and maintain function. When NGF declines, as it measurably does with age, neurons atrophy and eventually die. The loss is not evenly distributed: the memory-critical hippocampus and the attention-regulating prefrontal cortex are disproportionately affected.

NGF deficiency has been a therapeutic target in neurodegeneration research for decades. The challenge has always been delivery. NGF as a protein cannot cross the blood-brain barrier. Clinical trials of direct NGF infusion required neurosurgical implants and produced serious side effects. Small-molecule compounds that stimulate the body's own NGF production represent a fundamentally different and far more accessible approach — and that is precisely what lion's mane contains.

How hericenones and erinacines were discovered

The discovery of NGF-stimulating compounds in lion's mane began in the early 1990s. Japanese researchers isolating bioactive compounds from Hericium erinaceum identified a series of diterpenoid molecules — erinacines A, B, and C — from the fungal mycelium. These compounds were found to strongly promote NGF synthesis in astroglial cells, the support cells that surround and nourish neurons.

Subsequent research identified hericenones — a structurally distinct class of compounds isolated from the mushroom's fruiting body rather than its mycelium. Hericenones are cytoprotective: they protect neurons from cell death induced by ER stress and oxidative damage, complementing the NGF-stimulating activity of erinacines. Together, the two classes create a dual mechanism: erinacines promote the growth and maintenance of new neurons; hericenones help protect existing neurons from death.

Erinacines A, B, and C, isolated from the mycelia of Hericium erinaceum, were identified as strong stimulators of nerve growth factor synthesis, promoting NGF production in astroglial cells. Kawagishi et al., Tetrahedron Letters, 1994.

The blood-brain barrier and lion's mane

The blood-brain barrier is a selective membrane that separates circulating blood from the central nervous system. It allows small molecules, gases, and lipid-soluble compounds to cross while blocking larger proteins and most water-soluble compounds. NGF itself, as a protein, cannot cross this barrier.

Erinacines are small enough and lipophilic enough to cross. Animal studies have confirmed that erinacine A and erinacine S, when administered orally, reach brain tissue and stimulate endogenous NGF production in the central nervous system. This is direct stimulation inside the brain. The practical consequence is that oral consumption of lion's mane, in food or supplemental form, can elevate CNS NGF levels through a non-invasive dietary route. No other widely available food has this property.

Erinacine A and erinacine S derived from Hericium erinaceus mycelium were demonstrated to cross the blood-brain barrier in rat models, stimulating NGF synthesis in central nervous system tissue following oral administration. Tsai et al., 2021, as cited in Contato and Conte-Junior, Nutrients, 2025.

What this mechanism means clinically

The NGF-stimulating mechanism directly explains the clinical trial outcomes observed in human studies. The foundational 2009 Mori trial found that cognitive scores rose progressively over 16 weeks of lion's mane supplementation and declined again after discontinuation — a washout pattern consistent with progressive NGF-supported neuronal maintenance that reverses when the stimulus is removed.

The most rigorously designed human trial to date examined the specific NGF mechanism directly. In a 49-week study of 49 patients with mild Alzheimer's disease, participants receiving erinacine A-enriched lion's mane mycelium showed not only significantly less cognitive deterioration than placebo but also measurably higher plasma NGF levels at end of treatment.

In a double-blind placebo-controlled pilot trial of 49 patients with mild Alzheimer's disease, 49 weeks of erinacine A-enriched Hericium erinaceus mycelia supplementation resulted in significantly lower cognitive deterioration and measurably higher plasma NGF levels in the treatment group compared to placebo, providing direct human evidence for the NGF-stimulating mechanism of lion's mane. Li et al., Frontiers in Aging Neuroscience, 2020.

A 2025 narrative review confirmed that the capacity of Hericium erinaceus to stimulate NGF synthesis is the primary mechanism underlying its neuroprotective properties, supported by both in vitro, preclinical, and human clinical data. Contato and Conte-Junior, Nutrients, 2025.

A systematic review of 26 human and preclinical studies confirmed the neuroprotective effects of Hericium erinaceus, identifying NGF stimulation alongside antioxidant, anti-inflammatory, and anti-tumor mechanisms. Menon et al., Frontiers in Nutrition, 2025.

What this means for your plate

Lion's mane is categorically different from most functional foods in that it acts on a specific molecular pathway — NGF synthesis — whose role in brain aging is well established in research. Fresh lion's mane two to three times per week delivers hericenones and erinacines in the same whole-food form studied by the research.

Hericenones, the fruiting body compounds, are present in fresh lion's mane exactly as consumed. No extraction or processing required. The clinical trial evidence for the NGF mechanism was built, in large part, on whole mushroom preparations. Fresh lion's mane delivers the relevant bioactive compounds through the same dietary route the research validated.

Continue exploring the Lion's Mane science

• What Are the Health Benefits of Lion's Mane Mushroom?

• Can Lion's Mane Improve Memory and Focus? What the Clinical Trials Show

• Does Lion's Mane Help with Anxiety and Depression?

• What Does the Research Say About Lion's Mane and Alzheimer's Disease?